Medulloblastoma on the Move: How Tumor Cells Colonize the Leptomeninges – and How to Stop Them

Medulloblastoma is the most common malignant brain tumor in children. Patients who exhibit leptomeningeal metastasis – dissemination of tumor cells from the cerebellum to the membranes surrounding the brain and spinal cord – have particularly poor outcomes. Here we summarize our current understanding of the biology of leptomeningeal metastasis, including the route cells take to get to the leptomeninges and the signals that allow them to survive once they get there. We also examine emerging approaches to treatment, from targeted therapies and immunotherapies to strategies designed to bypass the blood-brain barrier. We conclude by highlighting vulnerabilities that may be exploited to improve outcomes for children with this disease.

Authors

Institutions

Publication Details

Journal
Cellular and Molecular Bioengineering
Published
2026-10-31
DOI
https://doi.org/10.1007/s12195-026-00958-2
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medulloblastoma on the Move: How Tumor Cells Colonize the Leptomeninges – and How to Stop Them

Daphne V. Koubourli, Robert J. Wechsler‐Reya, Matthew Gallitto, Elizabeth A. Thompson
Cellular and Molecular Bioengineering
Glioma Diagnosis and Treatment
article

Medulloblastoma on the Move: How Tumor Cells Colonize the Leptomeninges – and How to Stop Them

Daphne V. Koubourli, Robert J. Wechsler‐Reya, Matthew Gallitto, Elizabeth A. Thompson
article en

Abstract

Medulloblastoma is the most common malignant brain tumor in children. Patients who exhibit leptomeningeal metastasis – dissemination of tumor cells from the cerebellum to the membranes surrounding the brain and spinal cord – have particularly poor outcomes. Here we summarize our current understanding of the biology of leptomeningeal metastasis, including the route cells take to get to the leptomeninges and the signals that allow them to survive once they get there. We also examine emerging approaches to treatment, from targeted therapies and immunotherapies to strategies designed to bypass the blood-brain barrier. We conclude by highlighting vulnerabilities that may be exploited to improve outcomes for children with this disease.

Cellular and Molecular Bioengineering
NewYork–Presbyterian Hospital (US), Columbia University Irving Medical Center (US), Herbert Irving Comprehensive Cancer Center (US), Columbia University (US)
Openalex Percentile: Top 12%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Medulloblastoma on the Move: How Tumor Cells Colonize the Leptomeninges – and How to Stop Them — Daphne V. Koubourli, Robert J. Wechsler‐Reya, et al. · Cellular and Molecular Bioengineering (2026) | TGRS Research Map | TGRS